Clinical trial reportJournal of the European Academy of Dermatology and Venereology : JEADVPublished
Guselkumab for the treatment of patients with moderate-to-severe hidradenitis suppurativa: A phase 2 randomized study
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Journal of the European Academy of Dermatology and Venereology : JEADV
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Hidradenitis Suppurativa; Psoriasis; Treatment Outcome; Severity of Illness Index; Double-Blind Method; Infant, Newborn; Antibodies, Monoclonal, Humanized
- PubMed ID
- 37317022
- Added to directory
- Source checked